Korean Skincare Brand Mediheal Finds Footing in US Skincare Market

As US consumers increasingly turn to K-beauty for science-backed, results-driven skincare, global derma-cosmetic brand Mediheal continues to distinguish itself as a category leader, backed by record-setting sales performance at South Korea’s top influential beauty retailer, Olive Young.

Mediheal was reportedly named the No. 1 brand in total sales at Olive Young for a second straight year in 2024 and 2025, topping more than 3,000 brands and becoming reportedly the first to achieve this distinction twice since the retailer’s founding in 1999.

Mediheal earned four major honors at the Olive Young Awards including No. 1 in the Toner Pad category; Global Trend Best Performer with the Madecassoside Blemish Pad; Global Trend Rising with the Madecassoside Blemish seruml; and winner in the Mask category with Madecassoside Essential Sheet Mask.

Among the award-winning Olive Young products, Mediheal’s Madecassoside Blemish Pad ranked No. 1 in its category for the second consecutive year, and the Madecassoside Blemish Repair serum recorded an 820% increase in sales within one year of launch, solidifying madecassoside as a hero ingredient driving global demand.

“Success at Olive Young is especially meaningful because it is where consumers discover K-beauty trends first,” said Johanna Kim, CEO and Creative Director of Mediheal. “The performance of our madecassoside line validates our product strategy as we look ahead to 2026 and reinforces our focus on scaling proven innovation from Korea to the US and other global markets.”